In Vitro Selective Inhibition of Human UDP-Glucuronosyltransferase (UGT) 1A4 by Finasteride and Prediction of In Vivo Drug–Drug Interactions

    January 2015 in “ Toxicology Letters ”
    Seung Hwan Lee, Jung Tak Park, Do-Yun Kim, Soo Kyung Bae, Young-Won Chin, Euichaul Oh
    Image of study
    TLDR Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.
    The study found that finasteride selectively inhibits the UGT1A4 enzyme in vitro, which could potentially lead to drug-drug interactions in vivo. However, the in vivo concentration of finasteride is not high enough to cause significant inhibition of UGT1A4. The study suggests that caution should be taken when administering drugs that are metabolized by UGT1A4 in combination with finasteride.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results

    Related Community Posts Join

    6 / 1000+ results

      community Temporary alternative to finasteride?

      in Finasteride  87 upvotes 5 days ago
      A 23-year-old male plans to temporarily stop finasteride to donate plasma for financial reasons and seeks alternative hair loss treatments like minoxidil, ketoconazole, or RU58841 during this period. He is open to suggestions to prevent further hair loss until he can resume finasteride.

      community Sensitive liver, topical fin safe to try?

      in Finasteride  98 upvotes 1 week ago
      Topical finasteride is considered safer for the liver than oral finasteride due to less systemic absorption, but regular liver function tests are advised. The user is concerned about liver health due to a history of NAFLD and is exploring topical finasteride as a safer alternative.

    Related Research

    1 / 1 results